2021 Coronary Revascularization Guidelines-Lessons in the Importance of Data Scrutiny and Reappraisal of Evidence

JAMA Surg. 2023 Mar 1;158(3):233-234. doi: 10.1001/jamasurg.2022.4796.
No abstract available

Plain language summary

This Viewpoint discusses whether or not the evidence cited in the 2021 American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography & Interventions guidelines for coronary artery revascularization support downgrading coronary artery bypass grafting relative to medical therapy.

MeSH terms

  • Coronary Artery Disease*
  • Decision Making
  • Humans
  • Myocardial Revascularization
  • United States